JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
PUT
Carnival Corporation Ltd
CCL
$35.7B
| $3.04M | ﹤0.01% |
300,000
-181,800
| -38% | -$1.88M |
2020 Q2
11 quarters
|
|
3077
Larimar Therapeutics
LRMR
$289M
| $3.04M | ﹤0.01% |
671,857
+627,067
| +1,400% | +$3.28M |
2020 Q4
9 quarters
|
|
3078
Astrana Health
ASTH
$1.84B
| $3.04M | ﹤0.01% |
83,333
+11,940
| +17% | +$418K |
2018 Q2
19 quarters
|
|
3079
PUT
Regions Financial
RF
$23B
| $3.04M | ﹤0.01% |
+163,600
| New | +$3.56M |
2023 Q1
0 quarters
|
|
3080
Lucid Motors
LCID
$1.64B
| $3.03M | ﹤0.01% |
37,716
+5,372
| +17% | +$477K |
2020 Q3
10 quarters
|
|
3081
Vicor
VICR
$13.8B
| $3.03M | ﹤0.01% |
64,614
+8,523
| +15% | +$473K |
2016 Q1
28 quarters
|
|
|
CIM
3082
Chimera Investment
CIM
$770M
| $3.03M | ﹤0.01% |
179,158
+38,936
| +28% | +$745K |
2013 Q2
39 quarters
|
|
3083
Lightspeed Commerce
LSPD
$1.31B
| $3.03M | ﹤0.01% |
199,733
+31,422
| +19% | +$498K |
2020 Q3
10 quarters
|
|
|
TWO
3084
DELISTED
Two Harbors Investment
TWO
| $3.03M | ﹤0.01% |
206,080
+116,435
| +130% | +$1.89M |
2013 Q2
39 quarters
|
|
3085
Invesco S&P 500 Revenue ETF
RWL
$9.88B
| $3.03M | ﹤0.01% |
39,830
+11,416
| +40% | +$868K |
2021 Q1
8 quarters
|
|
|
FBMS
3086
DELISTED
The First Bancshares, Inc.
FBMS
| $3.03M | ﹤0.01% |
117,315
+5,331
| +5% | +$157K |
2017 Q4
21 quarters
|
|
3087
Levi Strauss
LEVI
$7.9B
| $3.03M | ﹤0.01% |
166,177
+95,878
| +136% | +$1.65M |
2019 Q1
16 quarters
|
|
3088
RLX Technology
RLX
$2.08B
| $3.03M | ﹤0.01% |
1,043,651
-532,138
| -34% | -$1.29M |
2021 Q1
8 quarters
|
|
3089
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.3B
| $3.02M | ﹤0.01% |
59,972
-53,322
| -47% | -$2.63M |
2022 Q4
1 quarter
|
|
|
SNBR
3090
DELISTED
Sleep Number
SNBR
| $3.02M | ﹤0.01% |
99,208
-30,252
| -23% | -$988K |
2014 Q3
34 quarters
|
|
3091
Invesco S&P 500 Pure Value ETF
RPV
$1.67B
| $3.01M | ﹤0.01% |
39,701
+11,805
| +42% | +$958K |
2013 Q2
39 quarters
|
|
|
BLU
3092
DELISTED
BELLUS Health Inc.
BLU
| $3.01M | ﹤0.01% |
418,416
+59,854
| +17% | +$464K |
2021 Q3
6 quarters
|
|
3093
Univest Financial
UVSP
$1.14B
| $3.01M | ﹤0.01% |
126,699
+91,564
| +261% | +$2.42M |
2015 Q4
29 quarters
|
|
3094
John B. Sanfilippo & Son
JBSS
$792M
| $3M | ﹤0.01% |
31,016
+8,086
| +35% | +$722K |
2013 Q2
39 quarters
|
|
3095
AllianzIM U.S. Equity Buffer20 Oct ETF
OCTW
$320M
| $3M | ﹤0.01% |
103,071
+398
| +0.4% | +$11.4K |
2022 Q4
1 quarter
|
|
3096
iShares Core 10+ Year USD Bond ETF
ILTB
$581M
| $2.99M | ﹤0.01% |
55,707
+1,840
| +3% | +$97.6K |
2014 Q3
34 quarters
|
|
3097
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.55B
| $2.99M | ﹤0.01% |
55,321
-159
| -0.3% | -$8.15K |
2013 Q2
39 quarters
|
|
3098
WisdomTree US Total Dividend Fund
DTD
$1.65B
| $2.99M | ﹤0.01% |
49,358
-330
| -0.7% | -$20.2K |
2018 Q2
19 quarters
|
|
3099
Amylyx Pharmaceuticals
AMLX
$3.52B
| $2.98M | ﹤0.01% |
101,700
+51,999
| +105% | +$1.81M |
2022 Q1
4 quarters
|
|
|
LUCK
3100
Lucky Strike Entertainment
LUCK
$721M
| $2.98M | ﹤0.01% |
175,626
+143,208
| +442% | +$2.12M |
2021 Q3
6 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.